Edgar L. Schuck, Ph.D.
Affiliations: | 2004 | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Pharmacy, PharmacologyGoogle:
"Edgar Schuck"Parents
Sign in to add mentorHartmut Derendorf | grad student | 2004 | UF Gainesville | |
(Pharmacokinetics and pharmacodynamics of ciprofloxacin in simulated microgravity.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wong H, Bohnert T, Damian-Iordache V, et al. (2017) Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective. Drug Discovery Today |
Schuck EL, Lai RY, Aluri J, et al. (2017) [P1-056]: POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) MODELING OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR, FOLLOWING SINGLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS Alzheimer's & Dementia. 13: P258-P258 |
Schuck E, Bohnert T, Chakravarty A, et al. (2015) Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape. The Aaps Journal. 17: 462-73 |
Yu Y, Logovinsky V, Schuck E, et al. (2014) Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects. Journal of Clinical Pharmacology. 54: 528-36 |
Schmidt S, Schuck E, Kumar V, et al. (2007) Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents - minimum inhibitory concentration versus time-kill curves. Expert Opinion On Drug Discovery. 2: 849-60 |
Schuck EL, Dalhoff A, Stass H, et al. (2005) Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form. Infection. 33: 22-8 |
Schuck EL, Derendorf H. (2005) Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents. Expert Review of Anti-Infective Therapy. 3: 361-73 |
Schuck EL, Grant M, Derendorf H. (2005) Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. Journal of Clinical Pharmacology. 45: 822-31 |
Graebe A, Schuck EL, Lensing P, et al. (2004) Physiological, pharmacokinetic, and pharmacodynamic changes in space. Journal of Clinical Pharmacology. 44: 837-53 |